Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy

Am J Hematol. 2019 Aug;94(8):E209-E213. doi: 10.1002/ajh.25505. Epub 2019 May 21.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antigens, CD19 / immunology*
  • Clinical Trials as Topic
  • Disease Progression
  • Female
  • Humans
  • Immunotherapy / methods*
  • Kaplan-Meier Estimate
  • Lymphoma, Large B-Cell, Diffuse / immunology
  • Lymphoma, Large B-Cell, Diffuse / therapy*
  • Male
  • Middle Aged
  • Receptors, Chimeric Antigen / immunology*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / transplantation*

Substances

  • Antigens, CD19
  • Receptors, Chimeric Antigen